nylidrin has been researched along with Dementia in 2 studies
Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, P | 1 |
| James, I | 1 |
| Jansen, W | 1 |
1 review available for nylidrin and Dementia
| Article | Year |
|---|---|
Cerebral vasodilators (second of two parts).
Topics: Aged; Animals; Betahistine; Cerebrovascular Circulation; Cerebrovascular Disorders; Cinnarizine; Cli | 1981 |
2 trials available for nylidrin and Dementia
| Article | Year |
|---|---|
Cerebral vasodilators (second of two parts).
Topics: Aged; Animals; Betahistine; Cerebrovascular Circulation; Cerebrovascular Disorders; Cinnarizine; Cli | 1981 |
[Analysis of the efficiency of Gerigoa-depot in a double-blind study].
Topics: Aged; Clinical Trials as Topic; Delayed-Action Preparations; Dementia; Drug Combinations; Drug Evalu | 1976 |